Outcomes of Patients Receiving Long-Term Corticosteroid Therapy Who Undergo Percutaneous Vertebroplasty

References

1. ↵
   Donnan PT, Libby G, Boyter AC, et al. The population risk of fractures attributable to oral corticosteroids. Pharmacoepidemiol Drug Saf 2005;14:177–86

   PubMed
2. ↵
   Jensen ME, Evans AJ, Mathis JM, et al. Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. AJNR Am J Neuroradiol 1997;18:1897–904

   Abstract
3. ↵
   Do HM, Kim BS, Marcellus ML, et al. Prospective analysis of clinical outcomes after percutaneous vertebroplasty for painful osteoporotic vertebral body fractures. AJNR Am J Neuroradiol 2005;26:1623–28

   Abstract/FREE Full Text
4. ↵
   Prather H, Van Dillen L, Metzler JP, et al. Prospective measurement of function and pain in patients with non-neoplastic compression fractures treated with vertebroplasty. J Bone Joint Surg Am 2006;88:334–41

   CrossRefPubMed
5. ↵
   Mathis JM, Petri M, Naff N. Percutaneous vertebroplasty treatment of steroid-induced osteoporotic compression fractures. Arthritis Rheum 1998;41:171–75

   CrossRefPubMedWeb of Science
6. ↵
   Harrop JS, Prpa B, Reinhardt MK, et al. Primary and secondary osteoporosis’ incidence of subsequent vertebral compression fractures after kyphoplasty. Spine 2004;29:2120–25

   CrossRefPubMedWeb of Science
7. ↵
   Singh AK, Pilgram TK, Gilula LA. Osteoporotic compression fractures: outcomes after single- versus multiple-level percutaneous vertebroplasty. Radiology 2006;238:211–20

   CrossRefPubMed
8. ↵
   Trout AT, Kallmes DF, Kaufmann TJ. New fractures after vertebroplasty: adjacent fractures occur significantly sooner. AJNR Am J Neuroradiol 2006;27:217–23

   Abstract/FREE Full Text